2010
DOI: 10.1016/j.biomaterials.2010.04.062
|View full text |Cite
|
Sign up to set email alerts
|

The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

25
303
2
3

Year Published

2011
2011
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 449 publications
(333 citation statements)
references
References 47 publications
25
303
2
3
Order By: Relevance
“…Therefore, particularly innovative nanoformulations have been developed to overcome these problems. Interestingly, it has been reported that encapsulation of curcumin in the form of curcuminoid mixture in micelles or nanoparticles retards the degradation of curcumin (18)(19)(20)(21)(22)(23). In this present study, we focused on the curcuminoid mixture because the anticancer and antiinflammatory activities of this mixture were stronger than that of pure curcumin alone and because the curcuminoid mixture has been used in most clinical trials (5,24).…”
Section: Introductionmentioning
confidence: 92%
“…Therefore, particularly innovative nanoformulations have been developed to overcome these problems. Interestingly, it has been reported that encapsulation of curcumin in the form of curcuminoid mixture in micelles or nanoparticles retards the degradation of curcumin (18)(19)(20)(21)(22)(23). In this present study, we focused on the curcuminoid mixture because the anticancer and antiinflammatory activities of this mixture were stronger than that of pure curcumin alone and because the curcuminoid mixture has been used in most clinical trials (5,24).…”
Section: Introductionmentioning
confidence: 92%
“…Cancer is the most dreaded disease and it involves abnormal cell growth with capability to spread to other parts of the body (Mohanty and Sahu 2010). Chemotherapy, surgery and radiotherapy strategies are being used for the treatment of cancers in current times but these measures of treatment are not effective against advanced stages of cancers (Feng and Chien 2003).…”
Section: Introductionmentioning
confidence: 99%
“…[52][53][54] These strategies include implantable curcumin carrier, 55 curcumin microparticles 56 and nanoparticles. 57 Pharmacokinetic studies reported that curcumin nano-formulation displayed a larger area under curve (AUC)-time curve as compared with free curcumin. [57][58][59] For example, encapsulation of curcumin by poly(lactic-co-glycolide) (PLGA) nanoparticles provided a significant higher maximal concentration (1000-fold increase) as compared with free curcumin following 60 min of i.v.…”
Section: Pathological Bone Environmentmentioning
confidence: 99%
“…administration in mice. 57 Curcumin nano-formulation has been explored especially for cancer therapy. [60][61][62] In this attempt, modulation of key properties of nanoparticles such as their size, surface charge and chemistry has been reported to favor their accumulation into the tumor tissue and optimize biological interactions with tumor cells.…”
Section: Pathological Bone Environmentmentioning
confidence: 99%